MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

American journal of cancer research (2017-06-01)

Guo-Qing Sui, Dan Fei, Feng Guo, Xi Zhen, Qiang Luo, Shuai Yin, Hui Wang

ABSTRACT

microRNA-338-3p (miR-338-3p) has been implicated in tumor development and progression in many types of cancers. However, the function and mechanism underlying the action of miR-383-3p in thyroid cancer remain unclear and were therefore investigated in this study by

MATERIALS

Product Number

Brand

Product Description

EHU067201

Sigma-Aldrich

MISSION^® esiRNA, targeting human AKT3